Decline in reported measles cases in Italy in the COVID-19 era, January 2020 - July 2022: The need to prevent a resurgence upon lifting non-pharmaceutical pandemic measures.

Autor: Facchin G; Italian National Institute of Health, Rome, Italy; University of Padua, Italy., Bella A; Italian National Institute of Health, Rome, Italy., Del Manso M; Italian National Institute of Health, Rome, Italy., Rota MC; Italian National Institute of Health, Rome, Italy., Filia A; Italian National Institute of Health, Rome, Italy. Electronic address: antonietta.filia@iss.it.
Jazyk: angličtina
Zdroj: Vaccine [Vaccine] 2023 Feb 10; Vol. 41 (7), pp. 1286-1289. Date of Electronic Publication: 2023 Jan 13.
DOI: 10.1016/j.vaccine.2023.01.021
Abstrakt: From January 2020 to July 2022, 120 measles cases were reported to the Italian national surveillance system, of which 105 had symptom onset in 2020, nine in 2021 and six in the first seven months of 2022. This represents a sharp decline compared to the time period immediately preceding the COVID-19 pandemic, most likely due to the non-pharmaceutical interventions implemented to prevent SARS-CoV2 transmission. Of 105 cases reported in 2020, 103 acquired the infection before a national lockdown was instituted on 9 March 2020. Overall, one quarter of cases reported at least one complication. As non-pharmaceutical pandemic measures are being eased worldwide, and considering measles seasonality, infectiousness, and its potential severity, it is important that countries ensure high vaccination coverage and close immunity gaps, to avoid risk of future outbreaks.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023. Published by Elsevier Ltd.)
Databáze: MEDLINE
Externí odkaz: